Vertex Pharmaceuticals Finance Lease Interest Expense remained flat by 0.0% to $1.43M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 77.4%, from $6.30M to $1.43M. Over 2 years (FY 2023 to FY 2025), Finance Lease Interest Expense shows a downward trend with a -61.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests higher debt-like obligations from finance leases or rising interest rates on new lease contracts.
The interest component of finance lease payments, representing the cost of borrowing inherent in the lease arrangement....
Comparable to interest expense on traditional debt, reflecting the financing cost of capital assets.
unp_finance_lease_interest_expense| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $38.80M | $25.20M | $5.70M |
| YoY Change | — | -35.1% | -77.4% |